During the last session, Oscar Health Inc. (NYSE:OSCR)’s traded shares were 2.4 million. The 52-week high for the OSCR share is $8.08, that puts it down -13.8 from that peak though still a striking 71.13% gain since the share price plummeted to a 52-week low of $2.05. The company’s market capitalization is $1.57B, and the average intraday trading volume over the past 10 days was 2.0 million shares, and the average trade volume was 3.58 million shares over the past three months.
Oscar Health Inc. (OSCR) received a consensus recommendation of a Hold from analysts. That translates to a mean rating of 2.90. OSCR has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 1 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.26.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Oscar Health Inc. (NYSE:OSCR) trade information
The stock’s 5-day price performance is -2.61%, and it has moved by 21.37% in 30 days. Based on these gigs, the overall price performance for the year is 49.79%. The short interest in Oscar Health Inc. (NYSE:OSCR) is 8.46 million shares and it means that shorts have 1.26 day(s) to cover.
The consensus price target of analysts on Wall Street is $7.07, which implies a decrease of -0.42% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5.40 and $9.00 respectively. As a result, OSCR is trading at a discount of -26.76% off the target high and 23.94% off the low.
Oscar Health Inc. (OSCR) estimates and forecasts
Statistics show that Oscar Health Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Oscar Health Inc. (OSCR) shares have gone up 163.94% during the last six months, with a year-to-date growth rate more than the industry average at 42.46% against 10.70. Yet analysts are ramping up their growth forecast for the fiscal year 2023. Revenue is predicted to grow 50.90% this quarter and then jump 47.30% in the quarter after that. In the rating firms’ projections, revenue will increase 41.30% compared to the previous financial year.
Revenue for the current quarter is expected to be $1.44 billion as predicted by 2 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to $1.37 billion by the end of Sep 2023. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $1.02 billion and $978.43 million respectively. In this case, analysts expect current quarter sales to grow by 41.50% and then jump by 40.40% in the coming quarter.
While earnings are projected to return 10.80% in 2023.
OSCR Dividends
Oscar Health Inc. is due to release its next quarterly earnings on May 09. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Oscar Health Inc. (NYSE:OSCR)’s Major holders
Oscar Health Inc. insiders own 1.51% of total outstanding shares while institutional holders control 85.69%, with the float percentage being 87.00%. Alphabet Inc. is the largest shareholder of the company, while 188 institutions own stock in it. As of Mar 30, 2023, the company held over 24.04 million shares (or 13.12% of all shares), a total value of $157.24 million in shares.
The next largest institutional holding, with 14.46 million shares, is of General Catalyst Group Management, LLC’s that is approximately 7.89% of outstanding shares. At the market price on Mar 30, 2023, these shares were valued at $94.6 million.
Also, the Mutual Funds coming in first place with the largest holdings of Oscar Health Inc. (OSCR) shares are Longleaf Partners Small-Cap Fund and Vanguard Total Stock Market Index Fund. Data provided on Dec 30, 2022 indicates that Longleaf Partners Small-Cap Fund owns about 14.57 million shares. This amounts to just over 8.04 percent of the company’s overall shares, with a $35.84 million market value. The same data shows that the other fund manager holds slightly less at 3.94 million, or about 2.17% of the stock, which is worth about $9.68 million.
